Role of endoscopic dacryocystorhinostomy in treating acquired lacrimal fistulae

Acquired lacrimal fistula occurs in an improperly and inadequately treated lacrimal sac abscess. This study was done to evaluate the success of endoscopic dacryocystorhinostomy (EDCR) in treating such lacrimal fistula. A retrospective analysis of nine cases of acquired lacrimal fistulae in seven patients, treated by EDCR without any external surgery was carried out. Cessation of epiphora and closure of fistula were considered, successful outcomes. All the nine fistulae closed, and all patients were relieved of their epiphora within two weeks of surgery. It can be concluded that EDCR is effective for treating an acquired lacrimal fistula.

Download Full-text

Role of mitomycin-C in endoscopic dacryocystorhinostomy with lacrimal sac stenting

International Journal of Otorhinolaryngology and Head and Neck Surgery ◽

10.18203/issn.2454-5929.ijohns20204624 ◽

2020 ◽

Vol 6 (11) ◽

pp. 2017

Author(s):

Jogeshwar Singh ◽

Manish Munjal ◽

Sanjeev Puri ◽

Parth Chopra ◽

Shubham Munjal ◽

...

Keyword(s):

Success Rate ◽

Mitomycin C ◽

Nasolacrimal Duct ◽

Study Group ◽

Lacrimal Sac ◽

Duct Obstruction ◽

Endoscopic Dacryocystorhinostomy ◽

Group I ◽

Primary Success

Background: This study critically evaluates the effectiveness of mitomycin-C in conventional endoscopic dacryocystorhinostomy (ENDODCR) that minimizes the reclosure of a neo-ostium by retaining an enlarged marsupialized lacrimal sac.Methods: The combined retrospective and prospective study included 24 patients in the study group, who underwent endoscopic dacryocystorhinostomy in the Department of Otorhinolaryngology and Ophthalmology in a period of 1.5 years (June 2006 to January 2008). Results: An 83.33% primary success rate was observed, without any serious complications. Obstruction of the neo-ostium with granulation tissue was observed in 20.83% cases. Overall, the success rate of group I was 91.67% as compared to 75% in group II.Conclusions: Intra operative mitomycin-C application is effective in increasing the success rate of DCR surgery in standard nasolacrimal duct obstruction, and no significant complications resulted from its use.

Download Full-text

The role of psa density in decision making to perform transperineal prostate biopsy in men with multi-parametric MRI Likert 2 or 3 scores: A retrospective analysis from a multi-centre cancer network study

European Urology ◽

10.1016/s0302-2838(21)01312-9 ◽

2021 ◽

Vol 79 ◽

pp. S1322

Author(s):

J. Fanshawe ◽

H. Warren ◽

C. Clark ◽

F. Kum ◽

M. Smekal ◽

...

Keyword(s):

Decision Making ◽

Retrospective Analysis ◽

Prostate Biopsy ◽

Psa Density ◽

Transperineal Prostate Biopsy ◽

Cancer Network

Download Full-text

Role of Octreotide in Conservative Management of Chyle Leak Post Neck Dissection in Cases of Head Neck Cancer: A Retrospective Analysis

Indian Journal of Otolaryngology and Head & Neck Surgery ◽

10.1007/s12070-021-02746-y ◽

2021 ◽

Author(s):

Vikas Gupta ◽

Gunjan Dwivedi ◽

Rajeev Chugh ◽

Pankaj Kumar Sahu ◽

Devendra Kumar Gupta ◽

...

Keyword(s):

Neck Dissection ◽

Retrospective Analysis ◽

Neck Cancer ◽

Conservative Management ◽

Head Neck Cancer ◽

Chyle Leak ◽

Head Neck

Download Full-text

Description of the role of pharmacist independent double checks during cognitive order verification of outpatient parenteral anti-cancer therapy

Journal of Oncology Pharmacy Practice ◽

10.1177/1078155221994319 ◽

2021 ◽

pp. 107815522199431

Author(s):

Jennifer P Booth ◽

Julie M Kennerly-Shah ◽

Amber D Hartman

Keyword(s):

Cancer Therapy ◽

Medication Error ◽

Retrospective Analysis ◽

Error Reporting ◽

Single Center ◽

Medication Error Reporting ◽

Anti Cancer ◽

Secondary Endpoints ◽

Type Frequency

Introduction To describe pharmacist interventions as a result of an independent double check during cognitive order verification of outpatient parenteral anti-cancer therapy. Methods A single-center, retrospective analysis of all individual orders for outpatient, parenteral anti-cancer agents within a hematology/oncology infusion center during a 30 day period was conducted. The primary endpoint was error identification rates during first and second verification. Secondary endpoints included the type, frequency, and severity of errors identified during second verification using a modified National Coordinating Council for Medication Error Reporting and Prevention Index. Results A total of 1970 anti-cancer parenteral orders were screened, from which 1645 received an independent double check and were included. The number of errors identified during first and second verification were 30 (1.8%) and 10 (0.6%) respectively; second verification resulted in a 33.3% increase in corrected errors. The 10 errors identified during second verification included: four rate transcriptions to optimize pump interoperability, three rate and/or volume modifications, two dosage adjustments, and one treatment deferral due to toxicity. The severity was classified as Category A for four (40%), Category C for three (30%), and Category D for three (30%) errors. This correlated to a low capacity for harm for seven (70%) and a serious capacity for three (30%) errors. Conclusions Second verification of outpatient, parenteral anti-cancer medication orders resulted in a 33.3% increase in corrected errors. Three errors detected during second verification were determined to have a serious capacity for harm, supporting the value of independent double checks during pharmacist cognitive order verification.

Download Full-text